Navigation Links
Injectable Drug Delivery to 2016
Date:9/13/2012

NEW YORK, Sept. 13, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Injectable Drug Delivery to 2016

http://www.reportlinker.com/p0967090/-Injectable-Drug-Delivery-to-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology

The past decade has seen a dramatic shift in terms of the types of approved injectable drugs, the diseases they target, and the devices used to deliver them. This shift has fostered change on several levels of the healthcare sector. The injectable drug segment has seen a marked increase in the level of drug/device integration, as prefilled syringes and specialized injection devices proliferate in response to safety and economic challenges posed by recombinant protein drugs, while administration of injectables has moved increasingly from practitioner offices and healthcare facilities to patient homes. This report examines the key therapeutic, product, market and regulatory factors for injectable drugs across ten major disease and therapeutic classes, providing essential insight and forecasts into the implications of this evolving landscape.

Highlights

  • Analyzes and evaluates the shifting landscape for injectable drug delivery and assesses the market impact of new and emerging injectable drug products by therapeutic indication
  • Analyzes syringe and injector device designs, feature/functionality, product branding, competing technologies and market development issues
  • Provides detailed descriptions of key injectable drug therapeutic market segments, market demographics, and business strategies
  • Forecasts Injectable drug product demand by indication and therapy to 2016• Profiles leading injection device companies, their product development activities, business strategies, and corporate alliances and affiliations Executive Summary

Injectable Drug Delivery Market Dynamics

The Injectable Drug Ecosystem Injectable Drug Demand Drivers Drug Development Factors Market Factors Technology Factors Competitive Landscape Autoinjectors Needle-free Injectors Pen Injectors Prefilled Syringes Safety Syringes Injectable Drug Demand Drivers Diseases and Indications Patient Demographics Developing Economies Risks and Opportunities

Injectable Drug Device Selection Criteria

Stability and Material Selection Issues Single vs Multi-Dose Devices Lyophilized Drugs/Reconstitution Syringe Safety/Sharps Protection Needle Configuration Strategies Disposable Drug Cartridges Human Engineering/Ergonomics Branding/Private Labeling

Injectable Drug Delivery – Device Segments

Autoinjectors Autoinjector-specific Selection Factors Part Counts and Device Cost Safety Features Needle Shielding Needle Insertion Depth Failsafe Activation Dose Inspection/Injection Confirmation Autoinjector Device Categories Reusable Autoinjectors Disposable Autoinjectors Product Specific Autoinjectors Drugs and Therapeutic Segments

Needle-free Injectors

Device Categories

End User/Practitioner/Mass Immunization Injectors

Prefilled Disposable Models

Refillable Cartridge Designs

Needle-free Injector-specific Selection Factors

Energy Source

Injection Site Selection

Pen Injectors Pen Injector Device Categories Standardized Pen Platforms Custom Pen Designs Reusable Pens Prefilled Pen Cartridges Disposable Pens Dual Chamber Pens Branded Drug/Pen Injector Product by Therapeutic Segment

Prefilled Syringes

Prefilled Syringe Device Categories

Glass Prefilled Syringes

Prefillable Glass Syringe Manufacturers and Branded Devices

Branded Drug/Prefilled Glass Syringe Products by Therapeutic Segment

Plastic Prefilled Syringes

Branded Prefillable Plastic Syringes

Drugs and Therapeutic Segments

Prefillable Safety Syringes

Prefilled Syringe-specific Selection Factors

PFS Manufacturing Factors

Fill-and-Finish Operations

Safety Syringes Safety Syringe Device Categories Prefillable Integrated Safety Syringes Non-Prefillable Integrated Safety Syringes Retractable Needle Manually Retractable Automatic Retractable Sliding Sheath

Injectable Drug Delivery – Therapeutic Segment Analysis & Forecasts

Anaphylaxis Anticoagulants Antivirals Autoimmune Diseases Emergency Medicine Hematopoietics Hormone Replacement Metabolic Diseases Neurology Reproductive Health Vaccines

Injectable Drug Therapeutics - Market Factors

Regulatory Factors and Issues FDA Regulations Regulating Combination Products Sharps Legislations Growth and Diversity of Safety Syringes Sharps Disposal Clinical Trial Factors Managed Care and Healthcare Economics

Company Profiles

To order this report: Drug_Delivery_Technology Industry: Injectable Drug Delivery to 2016

Nicolas Bombourg

Reportlinker

Email: nicolasbombourg@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Summer Is the Best Time for Injectable Treatments
2. Prodigy Generics and eVenus Announce the Launch of Oncology Injectable Irinotecan.
3. BioDelivery Sciences Announces Positive Results of Pivotal Pharmacokinetic Study Comparing BEMA Buprenorphine/Naloxone (BNX) to Suboxone
4. Philips continues to improve access to treatment for common cause of death in the U.S. with the delivery of its one-millionth AED
5. BioDelivery Sciences to Present at the Stifel Nicolaus 2012 Healthcare Conference
6. GeNO LLC Receives Four Additional Patents for Inhaled Nitric Oxide Delivery
7. BioDelivery Sciences Announces Completion of Enrollment in Pivotal Pharmacokinetic Study of BEMA Buprenorphine/Naloxone Compared to Suboxone
8. GeNO LLC Receives FDA Marketing Clearance For Its Inhaled Nitric Oxide Drug Delivery Device
9. AHM Announces New SVP Product Delivery
10. BioDelivery Sciences to Present at the 2012 Wedbush PacGrow Lifesciences Management Access Conference
11. BioDelivery Sciences and Endo Health Solutions Announce Initiation of Enrollment in the Phase 3 Program for BEMA Buprenorphine for Chronic Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2017)... Mich. , Sept. 18, 2017  PMD Healthcare ... Specialty Pharmacy of Kalamazoo, Mich. , ... hub service that expedites and streamlines patient and provider ... PD 2.0, and wellness management services.  ... device used to measure lung function for a variety ...
(Date:9/12/2017)... LAKES, N.J. , Sept. 12, 2017  Consumer reviews on ... Embrace Hearing as the number one company for hearing aids, ... ReSound™ and fifteen other brands. ... Embrace Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides ...
(Date:9/9/2017)...  Eli Lilly and Company (NYSE: LLY ... for lasmiditan, an investigational, oral, first-in-class molecule for the ... compared to placebo in the Phase 3 SPARTAN study. ... Congress of the International Headache Society (IHC) in ... today demonstrate lasmiditan,s potential to reduce pain and provide ...
Breaking Medicine Technology:
(Date:9/20/2017)... Raton (PRWEB) , ... September 20, 2017 , ... In ... Daily Brain Booster has already been receiving positive feedback from customers trying the product ... months. , Daily Brain Booster was developed by neurosurgeon Shawn Moore, MD, for ...
(Date:9/20/2017)... , ... September 20, 2017 , ... ... of older Americans at risk of price gouging for their prescription drugs, according ... (TSCL) . “Because Medicare isn’t negotiating on our behalf, there’s no consistency in ...
(Date:9/20/2017)... ... September 20, 2017 , ... ... “RECYCLED Ezekiel's Plan for Freedom from ADDICTION” is the creation of published ... the field of addiction and homeless services, including more than a decade of ...
(Date:9/20/2017)... ... ... “Psalms of Humidity”: is a fascinating depiction of daily struggles and the ... closer to God. “Psalms of Humidity” is the creation of published author, David Waldrop, ... his life are the very same things that have shaped him into the man ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
Breaking Medicine News(10 mins):